Robert L.  Dixon, Jr. net worth and biography

Robert Dixon, Jr. Biography and Net Worth

Director of Elevance Health
Robert L. Dixon Jr. serves as Independent Director of the Company. Mr. Dixon joined our board in June 2019. Mr. Dixon has owned The RD Factor, Inc., a digital and information technology consulting business, since December 2016. Mr. Dixon served at PepsiCo, Inc., a global food and beverage company, as Global Chief Information Officer and Senior Vice President from 2007 through 2016. Previously, Mr. Dixon held various positions with The Procter & Gamble Company, a consumer household products company, since 1977, including Vice President of Global Business Services. Mr. Dixon has served on the boards of Anthem, Inc., a health benefits company, since 2011, and Build-A-Bear Workshop, Inc., a specialty retailer, since February 2018. At the Georgia Institute of Technology, Mr. Dixon serves on the President’s Advisory Board, the College of Engineering Advisory Board and the College of Computing Advisory Board. He previously served on the CIO Advisory Board for IBM. Mr. Dixon holds a Bachelor of Science Degree in electrical engineering from The Georgia Institute of Technology.

What is Robert L. Dixon, Jr.'s net worth?

The estimated net worth of Robert L. Dixon, Jr. is at least $3.98 million as of July 19th, 2024. Mr. Dixon, Jr. owns 9,721 shares of Elevance Health stock worth more than $3,979,972 as of December 3rd. This net worth estimate does not reflect any other investments that Mr. Dixon, Jr. may own. Learn More about Robert L. Dixon, Jr.'s net worth.

How do I contact Robert L. Dixon, Jr.?

The corporate mailing address for Mr. Dixon, Jr. and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Robert L. Dixon, Jr.'s contact information.

Has Robert L. Dixon, Jr. been buying or selling shares of Elevance Health?

Robert L. Dixon, Jr. has not been actively trading shares of Elevance Health during the last quarter. Most recently, Robert L. Dixon, Jr. sold 305 shares of the business's stock in a transaction on Friday, July 19th. The shares were sold at an average price of $506.76, for a transaction totalling $154,561.80. Following the completion of the sale, the director now directly owns 9,721 shares of the company's stock, valued at $4,926,213.96. Learn More on Robert L. Dixon, Jr.'s trading history.

Who are Elevance Health's active insiders?

Elevance Health's insider roster includes Gail Boudreaux (President, CEO & Director), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Felicia Norwood (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.

Are insiders buying or selling shares of Elevance Health?

In the last year, insiders at the sold shares 6 times. They sold a total of 57,339 shares worth more than $28,701,403.88. The most recent insider tranaction occured on October, 18th when EVP Charles Morgan Kendrick Jr sold 7,417 shares worth more than $3,205,182.38. Insiders at Elevance Health own 0.3% of the company. Learn More about insider trades at Elevance Health.

Information on this page was last updated on 10/18/2024.

Robert L. Dixon, Jr. Insider Trading History at Elevance Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/19/2024Sell305$506.76$154,561.809,721View SEC Filing Icon  
7/21/2023Sell310$476.71$147,780.109,638View SEC Filing Icon  
6/6/2022Sell420$497.14$208,798.809,491View SEC Filing Icon  
5/27/2020Sell1,102$284.59$313,618.189,568View SEC Filing Icon  
7/26/2019Sell520$294.11$152,937.209,971View SEC Filing Icon  
5/18/2018Sell1,000$231.10$231,100.00View SEC Filing Icon  
See Full Table

Robert L. Dixon, Jr. Buying and Selling Activity at Elevance Health

This chart shows Robert L Dixon Jr's buying and selling at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevance Health Company Overview

Elevance Health logo
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $409.42
Low: $406.78
High: $412.34

50 Day Range

MA: $446.87
Low: $394.20
High: $533.73

2 Week Range

Now: $409.42
Low: $391.02
High: $567.26

Volume

379,846 shs

Average Volume

1,185,629 shs

Market Capitalization

$94.95 billion

P/E Ratio

14.93

Dividend Yield

1.60%

Beta

0.83